SCHEMBL5566012

SCHEMBL5566012

CC(C)C(CC(=O)Nc1ccc(Cl)cn1)NC(=O)c1ccc(C2(CN3CCCC3)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 10/20 0.44
▸ FPR1 P21462 1/20 0.44
▸ FPR2 P25090 1/20 0.44
▸ F2 P00734 1/20 0.42
▸ CCR1 P32246 1/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ NFKB1 P19838 2/20 0.41
▸ NFKB2 Q00653 2/20 0.41
▸ RELA Q04206 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ THRB P10828 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5566598 0.91 F10 (0.45) F10FPR1FPR2F2NPSR1
SCHEMBL5570947 0.85 HTT (0.51) F10FPR1FPR2F2NPSR1
SCHEMBL5669901 0.81 MAPK1 (0.47) F10FPR1FPR2F2NPSR1
SCHEMBL5569358 0.81 RAB9A (0.57) F10FPR1FPR2F2RAB9A
SCHEMBL5672229 0.81 F10 (0.48) F10FPR1FPR2HTTRAB9A
SCHEMBL5567062 0.77 F10 (0.46) F10F2CCR1SMN1; SMN2
SCHEMBL5643563 0.76 F10 (0.75) F10
SCHEMBL5642247 0.76 F10 (0.67) F10
SCHEMBL5642495 0.76 F10 (0.75) F10
SCHEMBL5642514 0.73 F10 (0.62) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
EP-1628668-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS Bristol-Myers Squibb Company (US) 2006-03-01 — — EP disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 — — WO disclosed
Send feedback